Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of…
By Ludwig Burger FRANKFURT (Reuters) - Novartis breast cancer drug Kisqali cut the risk of…
By Dawn Chmielewski (Reuters) - Netflix Inc shareholders on Thursday withheld their…
By Rajesh Kumar Singh CHICAGO (Reuters) - Southwest Airlines Co CEO Bob Jordan said on…
By Jonathan Stempel NEW YORK (Reuters) - Elon Musk is being accused of insider trading in…
By David Morgan, Richard Cowan and Moira Warburton WASHINGTON (Reuters) - A divided U.S.…
By Lucia Mutikani WASHINGTON (Reuters) - U.S. job openings unexpectedly rose in April and…
By Brendan Pierson (Reuters) -Johnson & Johnson on Wednesday faced the first trial in…
By Moira Warburton and David Morgan WASHINGTON (Reuters) - Legislation brokered by…
By Akash Sriram and Samrhitha A (Reuters) - Nvidia Corp briefly joined an elite club of…
(Reuters) - Activist investor Legion Partners has met Twilio Inc officials several times,…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.